Abstract
In an age of rapid advances inlife-prolonging treatment, patients and caregivers areincreasingly facing tensions in making end-of-lifedecisions. An examination of the history of healthcare in the United States reveals technological,economic, and medical factors that have contributed tothe problems of terminal care and consequently to themovement of assisted suicide. The movement has itsroots in at least two fundamental perceptions andexpectations. In the age of technological medicineenergized by the profit motive, dying comes at a highprice in suffering and in personal economic loss. Thefailure to provide affordable resources for terminalcare is the result of the marketplace in health care. The medical profession has been painfully slow inresponding to the challenges of terminal care, mainlybecause of the pressures of the marketplace and lackof adequate training. This has occurred at a time ofrapid advances in life-sustaining treatment and ofexpanding public awareness of personal rights underthe law. Overly aggressive treatment in the finalstages of terminal illness has enhanced anxieties overa painfully prolonged and expensive dying. Thesefactors have promoted the movement to assistedsuicide. In the U.S. debate of the issues, ethiciststend to argue abstractly without examiningadequately the context of terminal care that is thehealth care system. It is a system in dire need of areform that will remove it from the marketplace.
Similar content being viewed by others
REFERENCES
Emanuel EJ. Cost savings at the end of life: what do the data show? JAMA 1996; 275: 1907-1914.
Ahronheim JC, Morrison RS, Baskin SA, Morris J, Meier DE. Treatment of the dying in the acute care hospital. Arch Intern Med 1996; 15(18): 2094-2100.
Cher DJ, Lenert LA. Elderly HMO patients less likely to experience potentially ineffective care. JAMA 1997; 278: 1001-1007.
Faber-Langendoen K. A multi-institutional study of care given to patients dying in hospitals. Arch Intern Med 1996; 156: 2130-2136.
Koenig HG, Wildman-Hanlon D, Schmader K. Attitudes of elderly patients and their families toward physician-assisted suicide. Arch Intern Med 1996; 156: 2240-2248.
Stevens R. American Medicine and the Public Interest. New Haven, CT: Yale University Press, 1971.
Reiser SJ. Medicine and the Reign of Technology. Cambridge: Cambridge University Press, 1978.
Brown ER. Rockefeller Medicine Men. Berkeley: University of California Press, 1979.
Rizzo RF. Health care reform in the light of history. International Journal of Social Economics 1993; 20(11): 40-56.
Relman A. Reforming our health care system: a physician's perspective. The Key Reporter 1992; 58(1): 1-5.
Lewin/ICP: A Division of Health and Sciences Research, Inc. Critical Condition: America's Health Care in Jeopardy. 1988 Microfiche Supplement. Bethesda, MD: UPUB of America, 1989: 3-34.
Neale A. Prepared statement on limits/balance in clinical decisions concerning and policy decisions allocating health care resources. Hearings on “The Future of Health Care in America.” 100th Cong., 2nd sess. S. Hrg. 100-1038, Pr.1. Washington: GPO, 1988.
Schapira DV, Studnicki J, Bradham DD, Wolf P, Jarrett A. Intensive care, survival, and expense of treating critically ill cancer patients. JAMA 1993; 269: 783-786.
Iglehart JK. The end stage renal disease program N Engl J Med 1993; 328: 366-371.
Is the cost of terminal care treatment the issue? Drugs & Ther Perspect 1997; 9(10): 14-16. http://www.medscape.com/adis.
Choice in Dying, Inc. (1995-96), as amicus curiae, Supreme Court 95-1858 & 96-110. 1995-96. http://www.echonyc.com/-choice/sctofa.html, 2000.
Christakis NA, Asch DA. Biases in how physicians choose to withdraw life support. Lancet 1993; 342: 642.
The SUPPORT Principal Investigators. A controlled trial to improve care for seriously ill hospitalized patients. JAMA 1995; 274: 1591-1598.
Schneidman E, ed. Death: Current Perspectives. Palo Alto, California: Mayfield, 1976.
Kubler-Ross E. On Death and Dying. New York: Macmillan, 1969.
Kastenbaum R, Aisenberg R. The Psychology of Death. New York: Springer, 1972.
Holden C. Hospices: for the dying, relief from pain and fear. Science 1976; 193: 389.
Rizzo RF. Hospice; comprehensive terminal care. New York State J Med 1978; 78: 1902-1910.
Foley KM. The relationship of pain and symptom management to patient requests for physician-assisted suicide. J. Pain & Symptom Mngt 1991; 6: 289-290.
Von Roenn JH, Cleeland CS, Gonin R, Hatfield AK, Pandya KJ. Physician attitudes and practice in cancer management: A survey from the eastern cooperative oncology group. Ann Intern Med 1993; 119: 121.
Bernabie R, Gambassi G, Lapane K, Landi F, Gatsonis, C, Dunlop R, Lipsitz L, Steel K, Mor V. Management of pain in elderly patients with cancer. JAMA 1998; 279: 1877-1882.
Stephenson J. Experts say AIDS pain ‘dramatically undertreated.’ JAMA 1996; 276: 1369-1370.
Bonica JJ. Pain mechanism. Paper presented at the Lakes Area Regional Medical Education Program, Buffalo NY. January 20, 1975: 3-20.
Bonica JJ. Ventafridda V, eds. International Symposium on Pain of Advanced Cancer. (Vol. 2 of Advances in Pain Research and Therapy). New York: Raven Press, 1979.
Saunders, Cecily. Management of intractable pain. Proc Roy Soc Med 1963; 56: 195-197.
President's Commission for the Study of Ethical Problems in Medicine and Biomedical and Behavioral Research. Deciding to Forego Life-sustaining Treatment. Washington, D.C.: Government Printing Office, 1983.
Cleeland CS, Gonin R, Hatfield AK, Edmonson JH, Blum RH, Stewart JA, Pandya KJ. Pain and its treatment in outpatients with metastatic cancer. N Engl J Med 1994; 330: 592-596.
Chen I. Accused of murder. Hippocrates 1998; 12(8): 41-42, 43-47. http://www. medscape.com/time/hippocrates.
Weissman DE. Consultation in palliative medicine. Arch Intern Med 1997; 157: 733-737.
Billings JA, Block S. Palliative care in undergraduate medical education. JAMA 1997; 278: 733-738.
Science News Update. AMA task force addresses end of life care. November 22, 1995. http://www.ama.org/sci-pubs/sci-news/1995.
Chin AE, Hedberg K, Higginson GK, Fleming DW. Legalized physician-assisted suicide in Oregon-the first year's experience. N Engl J Med 1999; 340: 577-583.
Emanuel EJ, Battin MP. What are the potential cost savings from legalizing physician-assisted suicide? N Engl J Med 1998; 339: 167-172.
Covinsky KE, Landefeld CS, Teno J, Connors AF, Dawson N, Youngner S, Desbiens N, Lynn J, Fulkerson W, Reding D, Oye R, Phillips RS. Is economic hardship on the families of the seriously ill associated with patient and surrogate care preferences? Arch Intern Med 1996; 156: 1737-1741.
Thomasma D. When physicians choose to participate in the death of their patients. Journal of Law, Medicine & Ethics 1996; 24: 183-197.
Rizzo RF. Genetic testing and therapy: a pathway to progress and/or profit? International Journal of Social Economics 1999; 26: 109-133.
Stingl M. Euthanasia and health reform in Canada. Cambridge Quarterly of Healthcare Ethics 1998; 7: 348-362.
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Rizzo, R.F. Physician-Assisted Suicide in the United States: The Underlying Factors in Technology, Health Care and Palliative Medicine – Part One. Theor Med Bioeth 21, 277–289 (2000). https://doi.org/10.1023/A:1009948715185
Issue Date:
DOI: https://doi.org/10.1023/A:1009948715185